Topic: contract manufacturer
Private equity player Ampersand Capital Partners is backing another CDMO, this one targeted at sterile injectables.
South Korea’s JW Pharmaceutical has started targeting emerging markets with a deal for a plant in Vietnam.
South Korea's SK Holdings is rolling three API operations into a new unit, SK Pharmteco, and has put its headquarters in Sacramento, California.
A judge orders Allergan to turn over Botox production details; A U.S. senator urges the FDA to run surprise inspections; the FDA approves Daiichi's cancer drug.
Known for aggressive acquisitions of its own, CDMO Cambrex is now the target of a buyout bid—this time to the tune of $2 billion.
CDMO Fujifilm Diosynth has acquired from Biogen a biologics production facility in Denmark with about 800 employees.
Mylan’s EpiPen has had a troubled few years, and now the auto-injector's manufacturer—Pfizer—may offload its manufacturing contract.
Lonza is continuing an expansion binge for its pharma manufacturing as it leans more heavily on it to drive its growth.
GlaxoSmithKline will unload an API plant to Thermo Fisher Scientific for €90 million. The U.S. company says it is glad to get it.
The possible cross-contamination with peanut flour of Novartis' anemia drug Promacta occurred at a contract manufacturing site.